Brian Daniel Webster - Jul 17, 2025 Form 4 Insider Report for KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)

Role: President and Chief Executive Officer, Director
Signature: /s/ Brian Daniel Webster
Stock symbol: KMTS
Transactions as of: Jul 17, 2025
Transactions value $: $0
Form type: 4
Date filed: 7/21/2025, 05:20 PM
Previous filing: Mar 6, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Webster Brian Daniel	President and Chief Executive Officer, Director	C/O KESTRA MEDICAL TECHNOLOGIES, LTD., 3933 LAKE WASHINGTON BLVD NE, SUITE 200, KIRKLAND	/s/ Brian Daniel Webster	2025-07-21	0001877188

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KMTS	Common Shares	Award	$0	+88.2K	+28.52%	$0.00	398K	Jul 17, 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	KMTS	Options						1.78M	Jul 17, 2025	Common Shares	1.78M		Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units ("RSU") that entitle the Reporting Person to receive, at settlement, one common share of Kestra Medical Technologies, Ltd. Subject to the Reporting Person's continued service, the RSUs will vest 29,333 on July 17, 2026, 29,333 on July 17, 2027 and 29,334 on July 17, 2028.
F2	Includes 1,068,000 fully vested options and 712,000 options that will vest as follows: 356,000 of such options will vest on March 6, 2026, and the remaining 356,000 will vest monthly over the following year.

Remarks:

President and Chief Executive Officer